K., Gurbuz, S., Haupt, A., Benson, C
BOOK A CONSULTATION WITH AN EXPERIENCED AUSTRALIAN DOCTOR TODAY TO DISCUSS YOUR HAIR AND SCALP CONCERNS: CLICK HERE REFERENCES: Hamblin PS, Earnest A, Russell AW, Talic S, Zomer E, Zoungas S
However, clinical trials consistently demonstrate a dose-response relationship
In the Phase 2 retatrutide trial published in the New England Journal of Medicine (2023), participants at the highest dose (12 mg) achieved a mean body weight reduction of approximately 24.2% over 48 weeks
(Pharmacogenomics) The heritability of GLP-1 release is around 50%.[ref] Thus, while there is a fairly important genetic component, diet is also really important
The short half-life means drug accumulation from a double dose can cause severe GI side effects